140 related articles for article (PubMed ID: 10233749)
21. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
Weis JJ; Tedder TF; Fearon DT
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
[TBL] [Abstract][Full Text] [Related]
22. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
[TBL] [Abstract][Full Text] [Related]
23. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
[TBL] [Abstract][Full Text] [Related]
24. Complement mediates the binding of HIV to erythrocytes.
Horakova E; Gasser O; Sadallah S; Inal JM; Bourgeois G; Ziekau I; Klimkait T; Schifferli JA
J Immunol; 2004 Sep; 173(6):4236-41. PubMed ID: 15356175
[TBL] [Abstract][Full Text] [Related]
25. In vitro immune complex binding assay to examine the mechanism of immune complex trapping by human follicular dendritic cells (FDC).
Maeda K; Matsuda M; Degawa N; Nagashima R; Fuyama S; Ito M; Arai S; Imai Y
Adv Exp Med Biol; 1995; 378():317-9. PubMed ID: 8526083
[No Abstract] [Full Text] [Related]
26. Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell lines.
Rasmussen JM; Marquart HV; Rask R; Jepsen HH; Svehag SE
Complement; 1988; 5(2):98-107. PubMed ID: 2837360
[TBL] [Abstract][Full Text] [Related]
27. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
Iida K; Nadler L; Nussenzweig V
J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma.
Malaspina A; Moir S; Nickle DC; Donoghue ET; Ogwaro KM; Ehler LA; Liu S; Mican JA; Dybul M; Chun TW; Mullins JI; Fauci AS
J Virol; 2002 Sep; 76(17):8855-63. PubMed ID: 12163605
[TBL] [Abstract][Full Text] [Related]
29. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
Varga L; Thiry E; Füst G
Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
[TBL] [Abstract][Full Text] [Related]
30. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
31. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
Theofilopoulos AN; Dixon FJ; Bokisch VA
J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
[TBL] [Abstract][Full Text] [Related]
32. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.
Fang Y; Xu C; Fu YX; Holers VM; Molina H
J Immunol; 1998 Jun; 160(11):5273-9. PubMed ID: 9605124
[TBL] [Abstract][Full Text] [Related]
33. Complement dependent trapping of infectious HIV in human lymphoid tissues.
Bánki Z; Kacani L; Rusert P; Pruenster M; Wilflingseder D; Falkensammer B; Stellbrink HJ; van Lunzen J; Trkola A; Dierich MP; Stoiber H
AIDS; 2005 Mar; 19(5):481-6. PubMed ID: 15764853
[TBL] [Abstract][Full Text] [Related]
34. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
35. CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients.
Legendre C; Raphael M; Gras G; Lefevre EA; Feuillard J; Dormont D; Richard Y
Int Immunol; 1998 Dec; 10(12):1847-51. PubMed ID: 9885905
[TBL] [Abstract][Full Text] [Related]
36. Complement receptors CD21 and CD35 in humoral immunity.
Roozendaal R; Carroll MC
Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
[TBL] [Abstract][Full Text] [Related]
37. The anti-human CD21 antibody, BU33, identifies equine B cells.
Mayall S; Siedek E; Hamblin AS
J Comp Pathol; 2001 Jan; 124(1):83-7. PubMed ID: 11428193
[TBL] [Abstract][Full Text] [Related]
38. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
Edberg JC; Kimberly RP; Taylor RP
Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
[TBL] [Abstract][Full Text] [Related]
40. Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcgammaRIIb) in the lymphoid tissues of neonatal calves.
Chattha KS; Firth MA; Hodgins DC; Shewen PE
Vet Immunol Immunopathol; 2010 Sep; 137(1-2):99-108. PubMed ID: 20488561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
